Loading clinical trials...
Loading clinical trials...
A Phase II, Open-label, Multiple-dose Trial to Investigate the Safety and Efficacy of UB-421 Monotherapy in Substitution for Stable Antiretroviral Therapy in HIV Infected Adults
Conditions
Interventions
UB-421
Locations
1
Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Start Date
June 1, 2015
Primary Completion Date
July 1, 2016
Completion Date
July 1, 2016
Last Updated
October 31, 2017
NCT06602622
NCT06185452
NCT06902038
NCT03835546
NCT03212989
NCT04620304
Lead Sponsor
United BioPharma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions